Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics

D. Ahn, A. Barzi, R. A. Miksad, A. Surinach, F. A. Corvino, A. Valderrama, K. Mamlouk, S. Pulgar, T. Bekaii-Saab

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)viii251
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this